Grantham, Mayo, Van Otterloo & Co (GMO)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,397
Closed -$37.3K 712
2023
Q2
$37.3K Sell
14,397
-11,903
-45% -$30.8K ﹤0.01% 673
2023
Q1
$107K Buy
+26,300
New +$107K ﹤0.01% 676